Trodelvy (sacituzumab govitecan) for the Treatment of Advanced Triple-Negative Breast Cancer

Image 2-Trodelvy
Trodelvy directly delivers the cytotoxic drug, SN-38, a topoisomerase I inhibitor, to the cancer cell. Credit: US National Library of Medicine National Institutes of Health, Health & Human Services.